Neuroprotection for premature infants? Another perspective on caffeine

JAMA

Volumn 307, Issue 3, 2012, Pages 304-305

  Maitre, Nathalie L ^a   Stark, Ann R ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAFFEINE; CORTICOSTEROID; INDOMETACIN; PLACEBO; RETINOL; CENTRAL STIMULANT AGENT;

APNEA; BRAIN HEMORRHAGE; CHILD DEATH; DEVELOPMENTAL DISORDER; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG MECHANISM; EDITORIAL; GESTATIONAL AGE; HEALTH CARE COST; HUMAN; INFANT; LOW BIRTH WEIGHT; NEUROPROTECTION; NONHUMAN; OUTCOME ASSESSMENT; PATENT DUCTUS ARTERIOSUS; PATIENT ASSESSMENT; PREMATURITY; PRIORITY JOURNAL; SURVIVAL RATE; TREATMENT INDICATION; TREATMENT RESPONSE; COGNITIVE DEFECT; FEMALE; MALE; NOTE; VERY LOW BIRTH WEIGHT;

APNEA; CAFFEINE; CENTRAL NERVOUS SYSTEM STIMULANTS; COGNITION DISORDERS; FEMALE; HUMANS; INFANT, PREMATURE; INFANT, VERY LOW BIRTH WEIGHT; MALE;

EID: 84855996293     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2011.2026     Document Type: Editorial

References (18)

1. Hintz SR, Kendrick DE, Vohr BR, Poole WK, Higgins RD; National Institute of Child Health and Human Development Neonatal Research Network. Changes in neurodevelopmental outcomes at 18 to 22 months' corrected age among infants of less than 25 weeks' gestational age born in 1993-1999. Pediatrics. 2005; 115(6):1645-1651. (Pubitemid 43843175)
2. Hintz SR, Kendrick DE, Wilson-Costello DE, et al NICHD Neonatal Research Network. Early-childhood neurodevelopmental outcomes are not improving for infants born at <25 weeks' gestational age. Pediatrics. 2011;127(1):62-70.
3. Hack M, Taylor HG, Drotar D, et al. Chronic conditions, functional limitations, and special health care needs of school-aged children born with extremely low-birth-weight in the 1990s. JAMA. 2005;294(3):318-325. (Pubitemid 41043775)
4. Yeargin-Allsopp M, Van Naarden Braun K, Doernberg NS, Benedict RE, Kirby RS, Durkin MS. Prevalence of cerebral palsy in 8-year-old children in three areas of the United States in 2002: a multisite collaboration. Pediatrics. 2008;121 (3):547-554.
5. Centers for Disease Control and Prevention (CDC). Economic costs associated with mental retardation, cerebral palsy, hearing loss, and vision impairment -United States, 2003. MMWR Morb Mortal Wkly Rep. 2004;53(3):57-59.
6. Manuel J, Naughton MJ, Balkrishnan R, Paterson Smith B, Koman LA. Stress and adaptation in mothers of children with cerebral palsy. J Pediatr Psychol. 2003; 28(3):197-201. (Pubitemid 36403049)
7. Schmidt B, Davis P, Moddemann D, et al Trial of Indomethacin Prophylaxis in Preterms Investigators. Long-term effects of indomethacin prophylaxis in extremely-low-birth-weight infants. N Engl J Med. 2001;344(26):1966-1972. (Pubitemid 32568150)
8. Tyson JE, Wright LL, Oh W, et al National Institute of Child Health and Human Development Neonatal Research Network. Vitamin A supplementation for extremely-low-birth-weight infants. N Engl J Med. 1999;340(25):1962-1968. (Pubitemid 29288272)
9. Ambalavanan N, Tyson JE, Kennedy KA, et al National Institute of Child Health and Human Development Neonatal Research Network. Vitamin A supplementation for extremely low birth weight infants: outcome at 18 to 22months. Pediatrics. 2005;115(3):e249-e254. (Pubitemid 43373006)
10. Schmidt B, Anderson PJ, Doyle LW, et al. Survivial without disability to age 5 years after neonatal caffeine therapy for apnea of prematurity. JAMA. 2012; 307(3):275-282.
11. Schmidt B, Roberts RS, Davis P, et al Caffeine for Apnea of Prematurity Trial Group. Long-term effects of caffeine therapy for apnea of prematurity. N Engl J Med. 2007;357(19):1893-1902. (Pubitemid 350074685)
12. Bayley N. Bayley Scales of Infant Development. 2nd ed. San Antonio, TX: The Psychological Corp; 1993.
13. Schmidt B, Roberts RS, Davis P, et al Caffeine for Apnea of Prematurity Trial Group. Caffeine therapy for apnea of prematurity. N Engl J Med. 2006;354 (20):2112-2121. (Pubitemid 43736611)
14. Palisano RJ, Cameron D, Rosenbaum PL, Walter SD, Russell D. Stability of the gross motor function classification system. Dev Med Child Neurol. 2006; 48(6):424-428. (Pubitemid 43740901)
15. Hanna SE, Rosenbaum PL, Bartlett DJ, et al. Stability and decline in gross motor function among children and youth with cerebral palsy aged 2 to 21 years. Dev Med Child Neurol. 2009;51(4):295-302.
16. Connolly S, Kingsbury TJ. Caffeine modulates CREB-dependent gene expression in developing cortical neurons. Biochem Biophys Res Commun. 2010; 397(2):152-156.
17. Yoshimura H. The potential of caffeine for functional modification from cortical synapses to neuron networks in the brain. Curr Neuropharmacol. 2005; 3(4):309-316. (Pubitemid 41461247)
18. Hack M, Taylor HG, Drotar D, et al. Poor predictive validity of the Bayley Scales of Infant Development for cognitive function of extremely low birth weight children at school age. Pediatrics. 2005;116(2):333-341. (Pubitemid 44161457)